RxDoctor Payments Data

Neeraj Gupta

Internal Medicine · Long Beach, CANPI 1356504062

Payments from drug & device makers

$1,101,809in general payments, 2019–2025

Across 218 payments — averaging $5054.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$268K
  • Boehringer Ingelheim International GmbH$226K
  • Boehringer Ingelheim$149K
  • AbbVie$119K
  • Hoffmann-la Roche Limited$90K
  • Takeda Pharmaceuticals U.S.A., Inc.$70K
  • plus $180K from 13 others

What the payments were for

  • Food & beverage$120100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,101,809 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →